Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Gossamer Bio

Biotech & Life Sciences · San Diego, United States · Founded 2017 · IPO 2019 Thoroughbred

Focused on the discovery and development of novel and differentiated therapeutic products

Valuation
$152M
Market cap · May/2026
Revenue
$48M
Latest reported FY
Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

19 investors on Gossamer Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Omega Funds
ARCH Venture Partners
Series B+ 17 investors entered at this stage
Polaris Partners
Samsara BioCapital
Invus
Armistice Capital
Abu Dhabi Investment Authority
EcoR1 Capital
Nantahala Capital Management
Madison Avenue Partners
Rock Springs Capital
Octagon Capital Advisors
NEA
SilverArc Capital
Farallon Capital Management
Hillhouse Capital
Palo Alto Investors
Boxer Capital
Federated Hermes

Global footprint

Where Gossamer Bio has talent and traffic

Workforce by country
12 countries with
team presence
🇺🇸 United States86.1%
🇮🇪 Ireland3.5%
🇬🇧 United Kingdom2.6%
🇧🇷 Brazil0.9%
🇮🇹 Italy0.9%
Top 5 of 12 shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States49.4%
🇬🇧 United Kingdom15.6%
🇨🇦 Canada12.5%
🇮🇳 India6.9%
🇪🇸 Spain6.3%
Top 5 markets shown

Market sentiment

What the market is saying about Gossamer Bio

An AI-synthesized read of the highest-engagement posts about Gossamer Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gossamer Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles